open access
RECIST criteria and clinical practice
- Oncology Chair and Clinic, Jagiellonian University, Collegium Medicum, Krakow, Poland
open access
Abstract
Abstract
Title
RECIST criteria and clinical practice
Journal
Nowotwory. Journal of Oncology
Issue
Article type
Invited editorial
Pages
319-320
Published online
2021-10-13
Page views
6129
Article views/downloads
455
DOI
Bibliographic record
Nowotwory. Journal of Oncology 2021;71(5):319-320.
Authors
Piotr J. Wysocki
- Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer. 1981; 47(1): 207–214, doi: 10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6.
- Therasse P, Arbuck S, Eisenhauer E, et al. New Guidelines to Evaluate the Response to Treatment in Solid Tumors. J Natl Cancer Inst. 2000; 92(3): 205–216.
- Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer. 2009; 45(2): 228–247.
- Seymour L, Bogaerts J, Perrone A, et al. iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. The Lancet Oncology. 2017; 18(3): e143–e152.
- Płużański A. Evaluation of response to treatment — criteria RECIST 1.1. Nowotwory. Journal of Oncology. 2014; 64(4): 331–335.